Biogen Inc. (BIIB) is currently Undervalued by 40.38%

Biogen Inc. (BIIB) appears undervalued by approximately 40.38% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.

Upside (live) 40.38% (from live valuation API)
Confidence (live) 8/10 (High)

Confidence Score is based on the magnitude of upside or downside vs intrinsic value.

Fair value estimate

Unlock fair value

Current price

$208.46

Stock valuation checker

Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.

Explore Our Valuation Calculators

Intrinsic Value Calculator (DCF)ROE Calculator Stock Valuation Calculator

Why is Biogen Inc. overvalued or undervalued?

Based on intrinsic value, Biogen Inc. (BIIB) looks priced ahead of a cash-flow-based fair value that blends growth, reinvestment needs, and a risk-adjusted discount rate.

Compared to historical valuation, today’s multiple exceeds the range implied by the company’s own five-year average—suggesting the market is more optimistic than its own past pricing of similar fundamentals.

Market expectations embedded in the price imply a demanding bar for execution: revenue cadence, margin stability, and capital returns would need to accelerate to justify a sustained premium versus fair value.

Key metrics

P/E ratio: 35.4x
Revenue growth (TTM y/y): 8%
Profit margin: 10.1%
Fair value (model): Unlock

Next steps

Frequently asked questions — BIIB

Is BIIB overvalued right now?

A stock is overvalued when its market price sits above a reasonable fair value range. Use the live snapshot on this page for BIIB, then validate with fundamentals and peer multiples.

What is Biogen Inc.'s intrinsic value?

Our DCF, P/E Multiple, and P/S Multiple models estimate whether BIIB trades above or below fair value. At $208.46, Biogen Inc. currently looks undervalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.

How is Biogen Inc.'s intrinsic value calculated?

Tickerplace calculates BIIB's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.

Is BIIB undervalued right now?

Based on our 2026 valuation models, Biogen Inc. (BIIB) appears undervalued at $208.46 with about 40.4% upside to fair value. Treat this as a screen—verify fundamentals on the company profile.

Peers for BIIB: open their overvalued / undervalued view.

Instant valuation answer